Monday - Friday, 8:00 AM - 5:00 PM
After-Hours & Emergency Services Available

About Biotech Sciences

Biotech Sciences is a privately-owned life sciences support company with headquarters and laboratories in Baltimore, Maryland. 

Our Areas of Focus

Since our inception in 2001, Biotech Sciences has provided a spectrum of technical support services to organizations that develop health-related products. We focus our analytical and synthesis studies in the areas of pharmaceuticals, biology, nutrition, and dietary supplements, but we also offer research and development support for medical devices and related healthcare technologies.


In the area of synthesis, we complete studies at the milligram to small kilogram scale. Each product is well characterized for quality using analytical techniques, such as NMR spectrometry, mass spectrometry, FT-IR spectrometry, and HPLC. We have completed studies requiring, de novo synthesis using established pathways, using novel approaches, and purification and characterization of test samples provided by others. We have prepared pharmacopeial reference standards.



In the analytical area, we complete studies under protocols that are either fully compliant with current Good Manufacturing Practices (cGMP) or conform to, but do not claim, cGMP. Studies are fully documented as they are completed and closed with a study report. All records related to the study are archived. We have also completed method development and validation studies, as well as testing and stability studies.

Looking Forward

Here at Biotech Sciences, we will continue to offer our current services while adding new services to the synthesis and analytical aspects of what we do, i.e., ICP MS, Stability, DSC, and PXRD. In addition, we will add new contract services, including pre-formulation and formulation development for pharmaceutical, nutraceutical, and cosmetic companies. 

We've formed a strategic alliance with the University of the Sciences in Baltimore, allowing us the full use of their Industrial Pharmacy Laboratory (IPHL) without an initial investment. This partnership will allow us to support new services.